Determining the fate of seeded cells in venous tissue‐engineered vascular grafts using serial MRI

A major limitation of tissue engineering research is the lack of noninvasive monitoring techniques for observations of dynamic changes in single tissue‐engineered constructs. We use cellular magnetic resonance imaging (MRI) to track the fate of cells seeded onto functional tissue‐engineered vascular grafts (TEVGs) through serial imaging. After in vitro optimization, murine macrophages were labeled with ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles and seeded onto scaffolds that were surgically implanted as inferior vena cava interposition grafts in SCID/bg mice. Serial MRI showed the transverse relaxation times (T2) were significantly lower immediately following implantation of USPIO‐labeled scaffolds (T2=44±6.8 vs. 71±10.2 ms) but increased rapidly at 2 h to values identical to control implants seeded with unlabeled macrophages (T2=63±12 vs. 63±14 ms). This strongly indicates the rapid loss of seeded cells from the scaffolds, a finding verified using Prussian blue staining for iron containing macrophages on explanted TEVGs. Our results support a novel paradigm where seeded cells are rapidly lost from implanted scaffolds instead of developing into cells of the neovessel, as traditionally thought. Our findings confirm and validate this paradigm shift while demonstrating the first successful application of noninvasive MRI for serial study of cellular‐level processes in tissue engineering.—Harrington, J. K., Chahboune, H., Criscione, J. M., Li, A. Y., Hibino, N., Yi, T., Villalona, G. A., Kobsa, S., Meijas, D., Duncan, D. R., Devine, L., Papademetri, X., Shin'oka, T., Fahmy, T. M., Breuer, C. K. Determining the fate of seeded cells in venous tissue engineered vascular grafts using serial MRI. FASEB J. 25, 4150–4161 (2011). www.fasebj.org

[1]  Eva Syková,et al.  Nanotechnologies in regenerative medicine , 2010, Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy.

[2]  David N Firmin,et al.  Magnetic resonance imaging of ferumoxide-labeled mesenchymal stem cells seeded on collagen scaffolds-relevance to tissue engineering. , 2006, Tissue engineering.

[3]  M. Prince,et al.  Iron oxide‐enhanced MR lymphography: The evaluation of cervical lymph node metastases in head and neck cancer , 1997, Journal of magnetic resonance imaging : JMRI.

[4]  Brian K Rutt,et al.  Detection threshold of single SPIO‐labeled cells with FIESTA , 2005, Magnetic resonance in medicine.

[5]  Jeff W M Bulte,et al.  Monitoring cell therapy using iron oxide MR contrast agents. , 2004, Current pharmaceutical biotechnology.

[6]  High-resolution magnetic resonance imaging of iron-labeled myoblasts using a standard 1.5-T clinical scanner , 2004, Magnetic Resonance Materials in Physics, Biology and Medicine.

[7]  Yasuko Tomizawa,et al.  Autocrine angiogenic vascular prosthesis with bone marrow transplantation , 1996, Nature Medicine.

[8]  Narutoshi Hibino,et al.  Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. , 2005, The Journal of thoracic and cardiovascular surgery.

[9]  S. Primack,et al.  High-resolution CT: normal anatomy, techniques, and pitfalls. , 2001, Radiologic clinics of North America.

[10]  H. Honda,et al.  Effective cell-seeding technique using magnetite nanoparticles and magnetic force onto decellularized blood vessels for vascular tissue engineering. , 2007, Journal of bioscience and bioengineering.

[11]  J. Mayer,et al.  Intravital molecular imaging of small-diameter tissue-engineered vascular grafts in mice: a feasibility study. , 2010, Tissue engineering. Part C, Methods.

[12]  Yoshito Ikada,et al.  Evaluation of tissue-engineered vascular autografts. , 2006, Tissue engineering.

[13]  G Tellides,et al.  Initial evaluation of the use of USPIO cell labeling and noninvasive MR monitoring of human tissue‐engineered vascular grafts in vivo , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  Matthew P. Brennan,et al.  Development of a mouse model for evaluation of small diameter vascular grafts. , 2007, The Journal of surgical research.

[15]  M. Šamánek.  Children with congenital heart disease: Probability of natural survival , 1992, Pediatric Cardiology.

[16]  Ernst J. Rummeny,et al.  Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro , 2004, European Radiology.

[17]  Narutoshi Hibino,et al.  Late-term results of tissue-engineered vascular grafts in humans. , 2010, The Journal of thoracic and cardiovascular surgery.

[18]  H. Iida,et al.  3-Tesla magnetic resonance angiographic assessment of a tissue-engineered small-caliber vascular graft implanted in a rat. , 2010, Journal of biomedical materials research. Part B, Applied biomaterials.

[19]  N. Hibino,et al.  Tissue-engineered vascular autograft: inferior vena cava replacement in a dog model. , 2001, Tissue engineering.

[20]  Craig H Meyer,et al.  Technology Insight: in vivo cell tracking by use of MRI , 2006, Nature Clinical Practice Cardiovascular Medicine.

[21]  Y. Ikada,et al.  First Evidence That Bone Marrow Cells Contribute to the Construction of Tissue-Engineered Vascular Autografts In Vivo , 2003, Circulation.

[22]  Narutoshi Hibino,et al.  Tissue‐engineered vascular grafts form neovessels that arise from regeneration of the adjacent blood vessel , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  Narutoshi Hibino,et al.  Cell-seeding techniques in vascular tissue engineering. , 2010, Tissue engineering. Part B, Reviews.

[24]  M. Port,et al.  In vitro biomedical applications of functionalized iron oxide nanoparticles, including those not related to magnetic properties. , 2010, Contrast media & molecular imaging.

[25]  Sophie Laurent,et al.  Contrast agents: magnetic resonance. , 2008, Handbook of experimental pharmacology.

[26]  Klaas Nicolay,et al.  MRI contrast agents: current status and future perspectives. , 2007, Anti-cancer agents in medicinal chemistry.

[27]  Luigi Biancone,et al.  Improved route for the visualization of stem cells labeled with a Gd‐/Eu‐Chelate as dual (MRI and fluorescence) agent , 2004, Magnetic resonance in medicine.

[28]  Kathryn Sharer,et al.  In vivo detection of single cells by MRI , 2006, Magnetic resonance in medicine.

[29]  D. Kraitchman,et al.  Stem cell therapy: MRI guidance and monitoring , 2008, Journal of magnetic resonance imaging : JMRI.

[30]  J. Hare,et al.  Tracking cell fate with noninvasive imaging. , 2009, Journal of the American College of Cardiology.

[31]  Hiroyuki Honda,et al.  Novel methodology for fabrication of tissue-engineered tubular constructs using magnetite nanoparticles and magnetic force. , 2005, Tissue engineering.

[32]  Narutoshi Hibino,et al.  Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling , 2010, Proceedings of the National Academy of Sciences.

[33]  E Wintermantel,et al.  Vascular tissue engineering with magnetic nanoparticles: seeing deeper , 2007, Journal of tissue engineering and regenerative medicine.

[34]  S. Majumdar,et al.  Micrometer-sized iron oxide particle labeling of mesenchymal stem cells for magnetic resonance imaging-based monitoring of cartilage tissue engineering. , 2011, Magnetic resonance imaging.

[35]  Aaron M Mohs,et al.  Gadolinium(III)-based blood-pool contrast agents for magnetic resonance imaging: status and clinical potential , 2007, Expert opinion on drug delivery.

[36]  Narutoshi Hibino,et al.  Successful application of tissue engineered vascular autografts: clinical experience. , 2003, Biomaterials.

[37]  Narutoshi Hibino,et al.  Tissue-engineered vascular grafts: does cell seeding matter? , 2010, Journal of pediatric surgery.

[38]  Wei Liu,et al.  Detection and quantification of magnetically labeled cells by cellular MRI. , 2009, European journal of radiology.

[39]  Soo-jin Kim,et al.  Outcome of 200 patients after an extracardiac Fontan procedure. , 2008, The Journal of thoracic and cardiovascular surgery.

[40]  Jeff W M Bulte,et al.  In Vivo Magnetic Resonance Tracking of Magnetically Labeled Cells after Transplantation , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[41]  J. Frank,et al.  Cellular MRI and its role in stem cell therapy. , 2008, Regenerative medicine.

[42]  Peter M Jakob,et al.  Iron oxide labelling of human mesenchymal stem cells in collagen hydrogels for articular cartilage repair. , 2008, Biomaterials.

[43]  Matthew P. Brennan,et al.  Functional small-diameter human tissue-engineered arterial grafts in an immunodeficient mouse model: preliminary findings. , 2008, Archives of surgery.

[44]  Arend Heerschap,et al.  Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy , 2005, Nature Biotechnology.

[45]  Brian K Rutt,et al.  Imaging single mammalian cells with a 1.5 T clinical MRI scanner , 2003, Magnetic resonance in medicine.

[46]  Jean-Christophe Ginefri,et al.  High-resolution 1.5-Tesla magnetic resonance imaging for tissue-engineered constructs: a noninvasive tool to assess three-dimensional scaffold architecture and cell seeding. , 2010, Tissue engineering. Part C, Methods.

[47]  Alan P Koretsky,et al.  Antibody-mediated cell labeling of peripheral T cells with micron-sized iron oxide particles (MPIOs) allows single cell detection by MRI. , 2007, Contrast media & molecular imaging.

[48]  Martin J Graves,et al.  In Vivo Detection of Macrophages in Human Carotid Atheroma: Temporal Dependence of Ultrasmall Superparamagnetic Particles of Iron Oxide–Enhanced MRI , 2004, Stroke.

[49]  S Majumdar,et al.  Magnetic resonance imaging of iron oxide labelled stem cells: applications to tissue engineering based regeneration of the intervertebral disc. , 2008, European cells & materials.

[50]  Matthew P. Brennan,et al.  Small-diameter biodegradable scaffolds for functional vascular tissue engineering in the mouse model. , 2008, Biomaterials.

[51]  Anke Bernstein,et al.  Characterization of scaffolds for tissue engineering by benchtop-magnetic resonance imaging. , 2009, Tissue engineering. Part C, Methods.

[52]  Narutoshi Hibino,et al.  Tissue-engineered Vascular Grafts Demonstrate Evidence of Growth and Development When Implanted in a Juvenile Animal Model , 2008, Annals of surgery.

[53]  A. Turchetta,et al.  Clinical outcome of 193 extracardiac Fontan patients: the first 15 years. , 2006, Journal of the American College of Cardiology.

[54]  Elliot R. McVeigh,et al.  Serial Cardiac Magnetic Resonance Imaging of Injected Mesenchymal Stem Cells , 2003, Circulation.

[55]  Jeff W M Bulte,et al.  Iron oxide MR contrast agents for molecular and cellular imaging , 2004, NMR in biomedicine.

[56]  Jeremy N Skepper,et al.  Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro. , 2007, Biomaterials.

[57]  S. Colan,et al.  Functional outcome after the Fontan operation: factors influencing late morbidity. , 1997, The Journal of thoracic and cardiovascular surgery.

[58]  Mark J. Miller,et al.  Autonomous T cell trafficking examined in vivo with intravital two-photon microscopy , 2003, Proceedings of the National Academy of Sciences of the United States of America.